Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis

Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis

10.3389/fendo.2021.609110

Saved in:

Bibliographic Details
Main Authors:	Wong, Chloe, Lee, Ming Hui, Yaow, Clyve Yu Leon, Chin, Yip Han, Goh, Xin Lei, Ng, Cheng Han, Lim, Amanda Yuan Ling, Muthiah, Mark Dhinesh, Khoo, Chin Meng
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Review
Language:	English
Published:	FRONTIERS MEDIA SA 2021
Subjects:	Science & Technology Life Sciences & Biomedicine Endocrinology & Metabolism glucagon-like peptide-1 receptor agonist non-alcoholic fatty liver disease type 2 diabetes mellitus GLP-1RA meta-analysis
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/206120
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items

The effects of glucagon-like peptide (GLP)-1 receptor agonists on weight and glycaemic control in Prader-Willi syndrome: A systematic review
by: Ng, Nicholas Beng Hui, et al.
Published: (2022)

Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With Type 2 Diabetes: A Meta-Analysis
by: Wong, Chloe, et al.
Published: (2021)

Evaluating the Safety Profile of Semaglutide: An Updated Meta-Analysis
by: Rivera, Frederick Berro, et al.
Published: (2024)

Ligand-specific factors influencing GLP-1 receptor post-endocytic trafficking and degradation in pancreatic beta cells
by: Fang, Zijian, et al.
Published: (2021)

The role of arginine vasopressin in diabetes-associated glucagons secretion
by: Sirintorn Yibchok-anun, et al.
Published: (2008)

Can glucose-lowering medications improve outcomes in non-diabetic heart failure patients? A Bayesian network meta-analysis
by: Yeong, Trevor, et al.
Published: (2022)

MTORC1 inhibition drives crinophagic degradation of glucagon
by: Rajak, Sangam, et al.
Published: (2022)

Synaptotagmin-7 as a positive regulator of glucose-induced glucagon-like peptide-1 secretion in mice
by: Gustavsson, N., et al.
Published: (2014)

Fetuin-A and fetuin-B in non-alcoholic fatty liver disease: A meta-analysis and meta-regression
by: Pan, X., et al.
Published: (2021)

Relationship between fasting plasma glucagon level and renal function - A cross-sectional study in individuals with type 2 diabetes
by: Liu, J.-J., et al.
Published: (2021)

The Effectiveness of Exercise for Non-Alcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
by: HO YUN LING SELINA
Published: (2021)

ENGINEERING PROBIOTICS TO PRODUCE SHORT CHAIN FATTY ACIDS FOR THE MANAGEMENT OF METABOLIC SYNDROME
by: KIM HYE RIM
Published: (2019)

Prevalence and clinical associations of posttransplant fatty liver disease
by: Lim, L.G., et al.
Published: (2011)

Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primates
by: Eriksson, Olof, et al.
Published: (2020)

Non-alcoholic fatty liver disease in women – Current knowledge and emerging concepts
by: Eng, PC, et al.
Published: (2023)

In-vitro validation of potential modulators of non-alcoholic fatty liver disease (NAFLD)
by: Tang, Daryl Woon Tat
Published: (2024)

Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact
by: Tang, SY, et al.
Published: (2023)

MOLECULAR MECHANISM OF GLP-1 POTENTIATED INSULIN GRANULE EXOCYTOSIS
by: NEHA SHRESTHA
Published: (2015)

Impact of Metabolic Risk Factors on the Severity and Outcome of Patients with Alcohol Associated Acute-on-Chronic Liver Failure.
by: Duseja, Ajay, et al.
Published: (2021)

Oxidative stress in NAFLD : role of nutrients and food contaminants
by: Rives, Clémence, et al.
Published: (2021)

EXPLORING RECEPTOR TYROSINE KINASES IN THE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: BHAVE SAYALI SHRIVARDHAN
Published: (2023)

Synthesis and biological evaluation of dihydropyrano-[2,3-c]pyrazoles as a new class of PPARγ partial agonists
by: Qvortrup, Katrine, et al.
Published: (2017)

EFFECTS OF MIXED MEALS WITH SPECIAL FORMULATED RICE ON BLOOD GLUCOSE LEVELS OF HEALTHY VOLUNTEERS
by: YANG DIMENG
Published: (2020)

ROLE OF G9A-LIKE PROTEIN GLP IN EMBRYONAL RHABDOMYOSARCOMA
by: UPASANA BAJAJ
Published: (2021)

Inhaled β2-adrenergic agonists in asthma: The evolving dilemma
by: Hui, K.P.
Published: (2016)

Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease
by: Kim, Chun-Hyung, et al.
Published: (2015)

Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome
by: Tan, Chek Kun, et al.
Published: (2017)

Effects of adenosine receptor agonists on nitric oxide release in mouse during endotoxemia
by: Wei, M.H., et al.
Published: (2011)

Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease
by: Bhave, Sayali, et al.
Published: (2022)

Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
by: Jain, Mukul R., et al.
Published: (2019)

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
by: Kumar, Rahul, et al.
Published: (2023)

Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease
by: Zeng, Jialiu, et al.
Published: (2023)

PAX4 loss of function increases diabetes risk by altering human pancreatic endocrine cell development
by: Lau, Hwee Hui, et al.
Published: (2024)

EXPRESSION AND FUNCTION OF GLP IN MUSCLE DIFFERENTIATION
by: CHOI MIN HEE
Published: (2018)

Chemical constituents of Ficus septica Burm. F.
by: Ragasa, Consolacion Y., et al.
Published: (2016)

Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes
by: Zarei, Mohammad, et al.
Published: (2020)

A new treatment of menorrhagia using GnRH-agonist cyclically without prolonged down-regulation and loss of bone density: A case study
by: Chan, C.L.K., et al.
Published: (2013)

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological per-spective
by: Soon, G., et al.
Published: (2021)

Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.
by: Tan, Eunice Xiang-Xuan, et al.
Published: (2021)

Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor
by: Personnaz, Jean, et al.
Published: (2023)